UK is example to Europe on patient information, says industry
October 9, 2008Medical Communications patients
British pharma is free to provide necessary and sufficient information to patients about its drugs, and an example to be …
Lilly eyes oncology focus with ImClone acquisition
October 9, 2008Sales and Marketing Cancer, MA, lilly
Lilly is to buy ImClone for $6.5 billion after outbidding Bristol-Myers Squibb for the biotech company. Lilly says the acquisition …
GlycArt’s new cancer candidate to be developed with Roche
October 9, 2008Research and Development, Sales and Marketing GlycArt, Roche
Roche is to develop a potential cancer therapy with two business partners. Genentech, the Swiss biotech company GlycArt – wholly-owned …
Advertising start-up is UK’s ‘first virtual healthcare agency’
October 7, 2008Medical Communications digi
A new advertising agency has been launched as the UK’s first ‘virtual’ healthcare outfit, and aims to undercut traditional agencies …
Latest news from Datamonitor
October 6, 2008Sales and Marketing OTC
Is an Rx-to-OTC move the right prescription to protect pharma revenues and cut healthcare costs? The growing cost of developing …
GSK plans research job losses in UK
October 3, 2008Research and Development GSK, restructure
GlaxoSmithKline is set to cut about 850 jobs in early-stage research and development at sites across the world, including the …
Emerging confidence
October 2, 2008Research and Development, Sales and Marketing emerging markets, evidence-based medicine
The wisdom that emerging markets are vital to the pharmaceutical and biotechnology industry’s future has become a lot more conventional …
Osteoporosis drug Aclasta approved for use in men
October 2, 2008Sales and Marketing Novartis, aclasta, osteoporosis
Osteoporosis treatment Aclasta has been approved for an extended indication in the European Union.Novartis’ once-yearly infusion has now been given …
Long-acting Zyprexa gets green light
October 2, 2008Sales and Marketing lilly, psych
Lilly's Zypadhera has been recommended in Europe for use in stabilising schizophrenic patients who are already receiving treatment. The European …
Spiriva partners defend drug’s safety
October 2, 2008Sales and Marketing Boehringer, COPD, Spiriva, resp
Boehringer Ingelheim and Pfizer have released new data on Spiriva to defend the safety record of the chronic obstructive pulmonary …
Weak currency helps UK pharmaceutical industry
October 1, 2008Manufacturing and Production, Sales and Marketing parallel trade
Pharmaceutical companies operating in the UK are experiencing reduced competition from European parallel importers, thanks to the weakness of the …
Credit crunch hits European biotech
October 1, 2008Research and Development 2008, YIR, biotech
Europe’s biotech sector is being hit hard by the credit crunch, with small and medium-sized companies being starved of funding …
Overcoming barriers to access
September 30, 2008Sales and Marketing Europe, UK, market access, strategies
Latest news from Datamonitor
September 29, 2008Sales and Marketing par
Is cost containment impacting pharmaceutical innovation?With the cost of healthcare provision spiraling, governments and payers across the seven major markets …
MHRA unveils medicine information resource
September 29, 2008Medical Communications patients
UK regulators and the pharma industry have come together to launch a new website for patients. The 'mymedicine' site is …
Pradaxa approved by NICE
September 26, 2008Sales and Marketing NICE, Pradaxa, clot, cv
NICE has recommended Boehringer Ingelheim's novel anti-clotting pill Pradaxa, giving it a marketing edge over Bayer's rival treatment Xarelto. Pradaxa …
Lilly to reveal doctor payments
September 26, 2008Medical Communications, Sales and Marketing ethics
Lilly is to be the first pharmaceutical company to disclose payments made to US doctors for consultancy services and key …
Merck’s Kuvan set for European approval
September 26, 2008Sales and Marketing EU, Kuvan
Merck Serono's Kuvan is on track to become the first medicine approved in Europe for two rare neurological disorders. Regulatory …
Working Life: Ali Ross
September 25, 2008Medical Communications, Sales and Marketing Europe, Otsuka, communications
How did you find your way into this role?
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
